Search Results - "Keith C. Bible"

Refine Results
  1. 1
  2. 2
  3. 3

    Diagnosis and Management of Anaplastic Thyroid Cancer by Chintakuntlawar, Ashish V., MBBS, PhD, Foote, Robert L., MD, Kasperbauer, Jan L., MD, Bible, Keith C., MD, PhD

    “…Anaplastic thyroid cancer (ATC) is a devastating and usually incurable diagnosis. Clinical and pathologic diagnosis is best assessed at a tertiary center with…”
    Get full text
    Journal Article
  4. 4

    Bone metastases in thyroid cancer by Iñiguez-Ariza, Nicole M., Bible, Keith C., Clarke, Bart L.

    Published in Journal of bone oncology (01-04-2020)
    “…•Osseous metastases (OMs) occur in only 4% of all thyroid cancer patients but are associated with greatly increased morbidity and mortality.•OMs are about…”
    Get full text
    Journal Article
  5. 5

    Advanced radioiodine-refractory differentiated thyroid cancer: the sodium iodide symporter and other emerging therapeutic targets by Spitzweg, Christine, Prof, Bible, Keith C, Prof, Hofbauer, Lorenz C, Prof, Morris, John C, Prof

    Published in The lancet. Diabetes & endocrinology (01-10-2014)
    “…Summary Approximately 30% of patients with advanced, metastatic differentiated thyroid cancer have radioiodine-refractory disease, based on decreased…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Pazopanib enhances paclitaxel-induced mitotic catastrophe in anaplastic thyroid cancer by Isham, Crescent R, Bossou, Ayoko R, Negron, Vivian, Fisher, Kelly E, Kumar, Rakesh, Marlow, Laura, Lingle, Wilma L, Smallridge, Robert C, Sherman, Eric J, Suman, Vera J, Copland, John A, Bible, Keith C

    Published in Science translational medicine (02-01-2013)
    “…Anaplastic thyroid cancer (ATC) has perhaps the worst prognosis of any cancer, with a median survival of only about 5 months regardless of stage. Pazopanib…”
    Get more information
    Journal Article
  11. 11

    The anticancer agent chaetocin is a competitive substrate and inhibitor of thioredoxin reductase by Tibodeau, Jennifer D, Benson, Linda M, Isham, Crescent R, Owen, Whyte G, Bible, Keith C

    Published in Antioxidants & redox signaling (01-05-2009)
    “…We recently reported that the antineoplastic thiodioxopiperazine natural product chaetocin potently induces cellular oxidative stress, thus selectively killing…”
    Get more information
    Journal Article
  12. 12

    External beam radiation therapy for advanced/unresectable malignant paraganglioma and pheochromocytoma by Breen, William, Bancos, Irina, Young, William F., Bible, Keith C., Laack, Nadia N., Foote, Robert L., Hallemeier, Christopher L.

    Published in Advances in radiation oncology (01-01-2018)
    “…To evaluate the role of external beam radiation therapy (EBRT) for treatment of malignant paraganglioma (PGL) and pheochromocytoma (PCC). A retrospective…”
    Get full text
    Journal Article
  13. 13

    Operative intervention for recurrent adrenocortical cancer by Dy, Benzon M., MD, Wise, Kevin B., MD, Richards, Melanie L., MD, Young, William F., MD, Grant, Clive S., MD, Bible, Keith C., MD, PhD, Rosedahl, Jordan, BS, Harmsen, William S., MS, Farley, David R., MD, Thompson, Geoffrey B., MD

    Published in Surgery (01-12-2013)
    “…Introduction Adrenocortical cancer (ACC) recurs despite apparent complete resection. We examined the survival and palliative benefit of resection for recurrent…”
    Get full text
    Journal Article
  14. 14

    Evolving molecularly targeted therapies for advanced-stage thyroid cancers by Bible, Keith C., Ryder, Mabel

    Published in Nature reviews. Clinical oncology (01-07-2016)
    “…Key Points Advances in understanding the genomic and functional alterations contributing to the pathogenesis of thyroid cancers have opened new therapeutic…”
    Get full text
    Journal Article
  15. 15

    Development and Characterization of a Differentiated Thyroid Cancer Cell Line Resistant to VEGFR-Targeted Kinase Inhibitors by Isham, Crescent R, Netzel, Brian C, Bossou, Ayoko R, Milosevic, Dragana, Cradic, Kendall W, Grebe, Stefan K, Bible, Keith C

    “…Background: Vascular endothelial growth factor-targeted kinase inhibitors have emerged as highly promising therapies for radioiodine-refractory metastatic…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20